Maier C
Klinik für Anästhesiologie und Operative Intensivmedizin im Klinikum, Christian-Albrechts-Universität zu Kiel.
Anaesthesist. 1995 Dec;44(12):875-9. doi: 10.1007/s001010050225.
Angio-oedema is a recognised complication of angiotensin converting enzyme (ACE) inhibitor therapy, occurring in 0.1% to 0.5% of patients taking captopril, enalapril, or lisinopril. This is the first report of severe angio-oedema complicating therapy with quinapril, a new, long-acting drug. CASE REPORT. A 74-year-old female had been taking quinapril (10 mg/day) and diuretics (fixed combination of triamterene and hydrochlorothiazide) for arterial hypertension for 18 months without any complication. After a fracture of the ankle, the patient received spinal anaesthesia uneventfully for an osteosynthesis. Ten days postoperatively, she noted swelling of the lips and the left half of the tongue. Following intravenous injection of antihistamines and prednisolone, these symptoms regressed. However, a relapse occurred on the 16th postoperative day with rapidly increasing oedema of the lips, face, ventral collar area, and entire tongue. Despite high-dose steroids, dyspnoea developed within 2 h. Direct laryngoscopy was impossible, and a flexible bronchoscope was used for nasotracheal intubation. At this point, the diagnosis of ACE inhibitor-induced angio-oedema was made and quinapril was withdrawn. The patient recovered, tracheal extubation was performed after 48 h, and the later course was uneventful. DISCUSSION. This is the second report of angio-oedema as a postoperative complication in a patient on long-term and previously unremarkable ACE inhibitor therapy. The first reported case occurred immediately after oral intubation and was perhaps precipitated by mechanical irritation. In this case, it is likely that postoperative deterioration of renal function due to dehydration and diuretic therapy was the precipitant, as has been reported in patients on lisinopril without surgery. Despite a significant increase in angio-oedema associated with the use of long-acting ACE-inhibitors, there appears to be a lack of familiarity among anaesthesiologist and other emergency physicians concerning this adverse effect. Withdrawal of the drug is the only effective treatment. High-dose steroids may be helpful, but if there is beginning dyspnoea or stridor, early endoscopically controlled intubation or emergency tracheostomy is essential to avoid hypoxaemia and death, as has occurred in the past.
血管性水肿是血管紧张素转换酶(ACE)抑制剂治疗中一种公认的并发症,在服用卡托普利、依那普利或赖诺普利的患者中发生率为0.1%至0.5%。这是关于新型长效药物喹那普利治疗并发严重血管性水肿的首例报告。病例报告。一名74岁女性因动脉高血压服用喹那普利(10毫克/天)和利尿剂(氨苯蝶啶和氢氯噻嗪固定复方制剂)18个月,未出现任何并发症。踝关节骨折后,患者接受脊髓麻醉进行接骨手术,过程顺利。术后10天,她注意到嘴唇和左半侧舌头肿胀。静脉注射抗组胺药和泼尼松龙后,这些症状消退。然而,术后第16天复发,嘴唇、面部、颈部腹侧区域和整个舌头迅速出现水肿。尽管使用了大剂量类固醇,2小时内仍出现呼吸困难。无法进行直接喉镜检查,遂使用可弯曲支气管镜进行鼻气管插管。此时,诊断为ACE抑制剂诱发的血管性水肿,并停用喹那普利。患者康复,48小时后拔除气管插管,后续病程顺利。讨论。这是第二例关于长期服用ACE抑制剂且之前无明显异常的患者术后并发血管性水肿的报告。首例报告的病例在经口插管后立即发生,可能是由机械刺激诱发。在本病例中,脱水和利尿剂治疗导致的术后肾功能恶化可能是诱发因素,正如在未进行手术的赖诺普利治疗患者中所报道的那样。尽管使用长效ACE抑制剂会使血管性水肿显著增加,但麻醉医生和其他急诊医生似乎对这种不良反应缺乏了解。停药是唯一有效的治疗方法。大剂量类固醇可能有帮助,但如果开始出现呼吸困难或喘鸣,早期在内镜控制下插管或紧急气管切开对于避免低氧血症和死亡至关重要,过去曾发生过此类情况。